Human parvovirus B19 as a causative agent for rheumatoid arthritis.
about
Human parvovirus B19.The potential role of human endogenous retrovirus K10 in the pathogenesis of rheumatoid arthritis: a preliminary studyThe challenge of early synovitis: multiple pathways to a common clinical syndromeMacrophages in rheumatoid arthritisSeroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes.New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infectionsPathogenesis of human parvovirus B19 in rheumatic disease.Human endogenous retrovirus W activity in cartilage of osteoarthritis patients.Molecular mechanism of monocyte predominant infiltration in chronic inflammation: mediation by a novel monocyte chemotactic factor, S19 ribosomal protein dimer.Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2.High mutant frequency in populations of a DNA virus allows evasion from antibody therapy in an immunodeficient hostBioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissueParvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections?Why do we not have a cure for rheumatoid arthritis?Human parvovirus B19 induced apoptotic bodies contain altered self-antigens that are phagocytosed by antigen presenting cells.Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis.Parvovirus B-19 infection during pregnancy.Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening.Autoantibodies to citrullinated proteins: ACPA.Molecular aspects of rheumatoid arthritis: role of environmental factors.Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects.Glycosphingolipids as receptors for non-enveloped viruses.Diagnosis of in utero Parvovirus B19 infection and maternal immune response - the relevance of linear epitopes and advanced serologic testing.The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.Human Parvoviruses.Phospholipase A2 activity-dependent stimulation of Ca2+ entry by human parvovirus B19 capsid protein VP1Increased Numbers of CD4+CD25+ and CD8+CD25+ T-Cells in Peripheral Blood of Patients with Rheumatoid Arthritis with Parvovirus B19 Infection.Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis.Human parvovirus B19 infection mimicking systemic lupus erythematosus.Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL).Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology.Frequency of antiparvovirus B19 antibodies in rheumatoid arthritis and systemic lupus erythematosus.Parvovirus b19 persistence in abnormal thyroid tissue of a mature cystic ovarian teratoma: a case report.Hepatic inflammation resulting from localized, subcutaneous expression of Parvovirus VP1u capsid protein: Importance and implication.Human parvovirus B19 viraemia is associated with neither IgM positivity nor anaemia in patients with rheumatic diseases.Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease.Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis.Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells.
P2860
Q24532891-99902760-9354-4892-B3B8-1E7218975BCFQ24675355-A544DEEA-6169-4915-93F3-BBD64B95369EQ24805007-017A6443-2FDD-48E1-827E-6F9AF84E8A6AQ24806949-2E8829B0-96C9-413E-976C-BBE5564B735DQ33330672-D1490594-4AED-44C1-8764-94038FD01A3FQ33340668-F1D23D50-D770-440E-91F1-ED2D793F3FAEQ33866419-BB0CE21B-774F-4B3B-9F5F-BB9D6F5D2097Q33974299-EA32497D-E903-4EB1-AE07-93607D230966Q34024904-7299317E-681E-4A00-8391-BC00CFF8D043Q34033196-F589521C-0DCC-4F9B-A7A6-13B6BF2BF526Q34099140-6F606EF2-F453-42A0-AA34-697804E37696Q34364832-01E38A1B-97E6-418A-9636-86BC1CE80521Q34472287-AEB63ACD-2878-4DC4-9A27-895CB8702FD9Q34624583-CE186F08-E63C-4269-9861-E59B0E9453D9Q34626063-6B257B36-9436-474E-AA2F-6C37E0E82896Q34731262-E8F87783-499F-4BF3-A419-B0FA8E952E8EQ34776941-218391AF-EA89-4300-BE89-57A20CCB79ADQ35549317-613CB3DD-C325-41C0-BF20-1E150D7D5B29Q35691814-1CDE843A-68BE-4394-A414-F65290902545Q35902285-EB8F7707-1EA2-4B3D-9704-7FC7679D8FB6Q36086129-7A98ACDC-F23D-4871-A848-27CFAA2E7C2AQ37228795-2E073939-F5EC-4CB1-9751-8B29BFA8BBBCQ37878262-F811710D-11C5-4A02-8057-BA03DB08E775Q37945203-5D73F134-FE7B-47E4-9FDC-FEE86879D6E7Q38088715-2713A039-A910-4509-A369-662B0CFFA7F5Q38661867-70A58BAE-D00F-407C-A90A-8CA7E7A75821Q38996997-B3DAC43B-E8CA-4ADC-BF98-A0870F109581Q39305479-27D44014-15D4-4537-8600-703DF2371ABCQ40266903-96CA7827-A200-4407-970B-B219F393B462Q40430043-10EE03AC-8E94-4198-BCA9-BB4D224BB084Q40592816-6544B4B0-5AE3-4335-AB2A-59F8FB203090Q40613460-36710F3A-15DC-43FF-A0C0-D70037D811F2Q41927788-7244BBB8-2085-4704-B0C9-4D1ABC8C3528Q42215773-4FBF8553-6B45-4D0D-8334-679ED9F4DCDCQ42229102-44E6F4F2-63FC-4A9E-9C7F-BA2F51FAD006Q42338994-889AB80B-54A9-4E8B-A5C8-632A88561F48Q42956331-25E8210A-7EE2-4805-A028-66575AA744DDQ43127800-3DE1B78D-5D16-48D5-A20D-DD9A4842E3FBQ45015675-ABDB1B2E-5D89-4748-8A31-B160995C362EQ45061283-6CD4F705-5C8D-4FFF-9FA2-F4E65416E320
P2860
Human parvovirus B19 as a causative agent for rheumatoid arthritis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Human parvovirus B19 as a causative agent for rheumatoid arthritis.
@ast
Human parvovirus B19 as a causative agent for rheumatoid arthritis.
@en
type
label
Human parvovirus B19 as a causative agent for rheumatoid arthritis.
@ast
Human parvovirus B19 as a causative agent for rheumatoid arthritis.
@en
prefLabel
Human parvovirus B19 as a causative agent for rheumatoid arthritis.
@ast
Human parvovirus B19 as a causative agent for rheumatoid arthritis.
@en
P2093
P2860
P356
P1476
Human parvovirus B19 as a causative agent for rheumatoid arthritis.
@en
P2093
Munakata Y
Sugamura K
Takahashi Y
P2860
P304
P356
10.1073/PNAS.95.14.8227
P407
P577
1998-07-01T00:00:00Z